Shopping Cart
- Remove All
Your shopping cart is currently empty
SB 204990 is a lactone prodrug of SB-201076, a potent and specific ATP citrate lyase inhibitor.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $39 | In Stock | |
| 5 mg | $93 | In Stock | |
| 10 mg | $163 | In Stock | |
| 25 mg | $323 | In Stock | |
| 50 mg | $593 | In Stock | |
| 100 mg | $848 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $97 | In Stock |
| Description | SB 204990 is a lactone prodrug of SB-201076, a potent and specific ATP citrate lyase inhibitor. |
| In vitro | METHODS: Primary hepatocytes were treated with SB-204990 (10 μM, 16 hours) under different experimental conditions to determine the effects occurring early after exposure to the Acly inhibitor SB-204990. RESULTS Phosphorylation of pThr 172 Ampk and pSer 79 Acc was reduced in primary hepatocytes treated with SB-204990 for 16 hours, while markers of Sirt1 or mTOR activity were absent. [1] |
| In vivo | METHODS: Mice were treated with SB-204990 (30 mg/kg body weight; oral gavage; treatment for 3 hours) to determine whether SB-204990 could induce effects in mitochondria in vivo. RESULTS Freshly isolated liver mitochondria from mice showed blocking and limiting effects on ADP-induced and FCCP-induced increases in OCR, respectively. [1] |
| Molecular Weight | 389.27 |
| Formula | C18H22Cl2O5 |
| Cas No. | 154566-12-8 |
| Smiles | OC(=O)C[C@@]1(O)C[C@@H](CCCCCCc2ccc(Cl)cc2Cl)OC1=O |
| Relative Density. | 1.332 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 242 mg/mL (621.68 mM), Sonication is recommended. H2O: 10 mg/mL (25.69 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (12.84 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | ||||||||||||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||||||||||||
H2O/DMSO
DMSO
| |||||||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.